Developing Crowdsourced Training Data Sets for Pharmacovigilance Intelligent Automation

Alex Gartland, Andrew Bate, Jeffery L. Painter, Tim A. Casperson and Gregory Eugene Powell ()
Additional contact information
Alex Gartland: University of Central Florida
Andrew Bate: GlaxoSmithKline
Jeffery L. Painter: JiveCast
Tim A. Casperson: GlaxoSmithKline
Gregory Eugene Powell: GlaxoSmithKline

Drug Safety, 2021, vol. 44, issue 3, No 9, 373-382

Abstract: Abstract Introduction Machine learning offers an alluring solution to developing automated approaches to the increasing individual case safety report burden being placed upon pharmacovigilance. Leveraging crowdsourcing to annotate unstructured data may provide accurate, efficient, and contemporaneous training data sets in support of machine learning. Objective The objective of this study was to evaluate whether crowdsourcing can be used to accurately and efficiently develop training data sets in support of pharmacovigilance automation. Materials and Methods Pharmacovigilance experts created a reference dataset by reviewing 15,490 de-identified social media posts of narratives pertaining to 15 drugs and 22 medically relevant topics. A random sampling of posts from the reference dataset was published on Amazon Turk and its users (Turkers) were asked a series of questions about those same medical concepts. Accuracy, price elasticity, and time efficiency were evaluated. Results Accuracy of crowdsourced curation exceeded 90% when compared to the reference dataset and was completed in about 5% of the time. There was an increase in time efficiency with higher pay, but there was no significant difference in accuracy. Additionally, having a social media post reviewed by more than one Turker (using a voting system) did not offer significant improvements in terms of accuracy. Conclusions Crowdsourcing is an accurate and efficient method that can be used to develop training data sets in support of pharmacovigilance automation. More research is needed to better understand the breadth and depth of possible uses as well as strengths, limitations, and generalizability of results.

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-020-01028-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01028-w

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-020-01028-w

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().